Rapport Therapeutics, Inc. RAPP Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s total operating expenses?
- Rapport Therapeutics, Inc. (RAPP) reported total operating expenses of $44.22M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Rapport Therapeutics, Inc.'s total operating expenses increased by 63.1% year-over-year, from $27.11M to $44.22M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s total operating expenses?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s total operating expenses has grown at a 86.0% compound annual growth rate (CAGR), from $36.18M to $125.1M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.